An Evaluation AZD2014 Alone and in Combination With Rituximab in Relapsed/Refractory Diffuse Large B Cell Lymphoma
Clinical trial NCT02752204 · COMPLETED
Trial details
- NCT number
- NCT02752204
- Sponsor
- University of Birmingham
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2017-09-07
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.